Jim Collins is a Core Faculty member at the Wyss Institute. He is also the Termeer Professor of Bioengineering in the Department of Biological Engineering and Institute for Medical Engineering & Science at MIT and is affiliated with the Broad Institute. His research group works in synthetic biology and systems biology, with a particular focus on using network biology approaches to study antibiotic action, bacterial defense mechanisms, and the emergence of resistance. James will join SynBioBeta founder John Cumbers for a conversation about the state of the synthetic biology industry. In light of COVID-19, we’ll also ask what the coronavirus pandemic means to innovation, our community, and our relationship with society. They’ll discuss:
- How synthetic biology has surpassed expectations, and the work that remains
- What his experience tells him about his outlook on the coronavirus response
- How coronavirus is shaping the public relationship with science
- The most important trends of the next five years
This event will be happening virtually.